A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
Live Science on MSN7d
E. coli in the gut may fuel a 'chain reaction' leading to Parkinson's, early study suggestsTwo recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
In addition, they often have milder symptoms, especially in the early stages ... could be a promising candidate diagnostic ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Does inhibiting TMEM16F actually reduce the symptoms of Parkinson's disease? Does the lipid composition of cell membranes ...
Does inhibiting TMEM16F actually reduce the symptoms of Parkinson's disease? Does the lipid composition of cell membranes ...
News Medical on MSN1d
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
While Parkinson’s disease (PD) has a large and highly generalised therapeutic ... and therapies addressing non-motor symptoms ...
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback